Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/23/2008WO2008126693A1 Remedy and diagnostic for mitochondrial dysfunction brain disease
10/23/2008WO2008126652A1 Composition for external application to skin
10/23/2008WO2008126587A1 Anti-fatigue agent
10/23/2008WO2008126398A1 Cytidine derivative-containing antitumor agent for continuous intravenous administration
10/23/2008WO2008126367A1 Ataractic agent and functional food
10/23/2008WO2008126363A1 Drug for preventing and/or treating fatty liver or nonalcoholic fatty liver disease
10/23/2008WO2008126123A2 Water-soluble coronene derivatives active as inhibitors of telomerase
10/23/2008WO2008126098A1 Extended release pharmaceutical formulation of propranolol hydrochloride
10/23/2008WO2008126094A1 Treatment of myocarditis using fts
10/23/2008WO2008126088A2 Anti-pyretic vasodilators
10/23/2008WO2008126034A2 Oxazolidinone antibiotics
10/23/2008WO2008126024A2 Oxazolidinone antibiotic derivatives
10/23/2008WO2008125988A1 Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
10/23/2008WO2008125945A2 3-amido-pyrrolo [3, 4-c] pyrazole-5 (1h, 4h, 6h) carbaldehyde derivatives as inhibitors of protein kinase c
10/23/2008WO2008125891A2 Pyrimidinyl-piperazines useful as dopamine d3 /d2 receptor ligands
10/23/2008WO2008125874A1 Benzofuran- carboxamide derivatives as antiviral agents
10/23/2008WO2008125843A1 Pharmaceutical compositions
10/23/2008WO2008125839A2 Pyrimidine derivatives as inhibitors of phosphatidylinositol-3-kinase
10/23/2008WO2008125835A1 2-morpholin-4-yl-pyrimidines as pi3k inhibitors
10/23/2008WO2008125833A1 Pharmaceutical compounds
10/23/2008WO2008125828A2 Oligo-guluronate and galacturonate compositions
10/23/2008WO2008125820A1 Combination therapy comprising azd2171 and azd6244 or mek-inhibitor ii
10/23/2008WO2008125811A1 N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
10/23/2008WO2008125778A2 Rehydration composition for preparing a solute by reconstitution in water
10/23/2008WO2008125714A1 Use of l-carnitine for treating arterial hypertension
10/23/2008WO2008125674A1 Use of dimiracetam in the treatment of chronic pain
10/23/2008WO2008125658A1 4,5,11,11a-tetrahydro-1h,6h-oxazolo[3',4':1,6]pyrido[3,4-b]indol-3-one derivatives and therapeutic use thereof
10/23/2008WO2008125633A2 Egfr inhibitors for treatment and diagnosis of metastatic prostate cancer
10/23/2008WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008WO2008125600A2 Pyrazole derivatives as p2x7 modulators
10/23/2008WO2008125599A1 2-carboxy thiophene derivatives as anti-viral agents
10/23/2008WO2008125594A1 Pyrrolo (3, 2, 1-ij) quinoline-4-one derivatives for treating tuberculosis
10/23/2008WO2008125583A1 Ethynylated heterodinucleoside phosphate analogs, method for the production thereof, and use thereof
10/23/2008WO2008125570A1 New bradykinin b1 antagonists
10/23/2008WO2008125487A1 Diphenyl-dihydro-imidazopyridinones
10/23/2008WO2008125424A1 Use of oligotide for the treatment of renal diseases
10/23/2008WO2008125423A1 Non-ionizable hydrophobic galenical system
10/23/2008WO2008125412A1 Crystalline forms of atorvastatin 4-(nitrooxy) butyl ester
10/23/2008WO2008125388A1 Pharmaceutical compositions comprising irbesartan
10/23/2008WO2008125366A2 Treatment of autoimmune diseases
10/23/2008WO2008125349A1 Spiro-pyrano-pyrazole derivatives
10/23/2008WO2008125348A1 Pyrano-pyrazole-amines
10/23/2008WO2008125337A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008125296A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008125231A1 Ginsenosides and extracts containing them combined with dexpanthenol
10/23/2008WO2008125215A1 Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
10/23/2008WO2008125210A1 Quinoline and naphthalene derivatives, processes for their preparation and their use in treatment of inflammatory diseases
10/23/2008WO2008125116A2 Upar inhibition
10/23/2008WO2008125111A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
10/23/2008WO2008125035A1 Sweetener granula
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008WO2008125008A1 Cyclohepta[b]pyridine compounds, preparation method and usage thereof as well as pharmaceutical compositions containing the compounds
10/23/2008WO2008125006A1 Preparation processes for ivabradine hydrochloride and its stable crystalline form
10/23/2008WO2008125004A1 Use of 21 (s) argatroban for treating thrombosis and inhibiting platelet aggregation
10/23/2008WO2008124994A1 A green environmental protection feed additive for fowls and domestic animals and its preparation method
10/23/2008WO2008124940A1 Use of cyclohexanehexol derivatives in the treatment of ocular diseases
10/23/2008WO2008124931A1 Use of cyclohexanehexol derivatives in the treatment of amyotrophic lateral sclerosis
10/23/2008WO2008124930A1 Use of cyclohexanehexol derivatives for the treatment of polyglutamine diseases
10/23/2008WO2008124929A1 USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF α-SYNUCLEINOPATHIES
10/23/2008WO2008124927A1 Sirna against thymidylate synthase and uses thereof in cancer treatment regimens
10/23/2008WO2008124922A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
10/23/2008WO2008124907A2 Resveratrol-containing composition for modulating bone formation
10/23/2008WO2008124878A1 Non-steroidal compounds
10/23/2008WO2008107478A8 Quinolinone derivatives as parp and tank inhibitors
10/23/2008WO2008107334A3 Process for the synthesis of glyt-1 inhibitors
10/23/2008WO2008105925A3 COMPOUNDS AND METHODS FOR MODULATING β-CATENIN/SMAD-7 INTERACTIONS
10/23/2008WO2008101907A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
10/23/2008WO2008100463B1 3,4-dihydr0-l,4-benz0xazine, 3, 4-dihydr0-1, 4-benzothiazine and 1,2,3,4-tetrahydro-quinoxaline derivatives as alpha2c adrenoreceptor agonists
10/23/2008WO2008100448A3 Method of treating cell proliferative disorders using growth hormone secretagogues
10/23/2008WO2008100426A3 Substituted pyridine n-oxide herbicides
10/23/2008WO2008099210A3 Piperazine derivatives for treatment of ad and related conditions
10/23/2008WO2008099081A3 Novel triazabenzo[α]naphtho[2,l,8-cde]azulene derivatives, method for preparing the same and pharmaceutical compositions containing the same
10/23/2008WO2008098329A8 Pharmaceutical composition, pharmaceutical product, obtaining processes of pharmaceutical compounds and use of such compounds for treating erectile dysfunction
10/23/2008WO2008097538A8 Therapeutic agents
10/23/2008WO2008097535A3 Method of treating atherosclerosis, dyslipidemias and related conditions
10/23/2008WO2008097112B1 Amidinoanthracycline antibiotics for use in the treatment of viral infections
10/23/2008WO2008090357A3 N, n; -substituted piperazines binding to melanocortin receptor
10/23/2008WO2008088864A3 Matrix metalloproteinase-9-related methods
10/23/2008WO2008087366A3 Substituted 3-phenyl-1-(phenylthienyl)propan-1-one and 3-phenyl-1-(phenylfuranyl)propan-1-one derivatives, and preparation and use of same
10/23/2008WO2008086783A3 Platinum complex
10/23/2008WO2008083330A3 Methods for enhancing exercise performance
10/23/2008WO2008081009A3 Amorphous rimonabant and rimonabant solvates and processes for their preparation
10/23/2008WO2008080810A3 Composition comprising cocoa fibre
10/23/2008WO2008079674A3 Processes for making cyclic lipid implants for intraocular use
10/23/2008WO2008076981A3 Inhibitors of ll-37- mediated immune reactivity to self nucleic acids
10/23/2008WO2008075162A3 Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction
10/23/2008WO2008073593A3 Processes to prepare antimicrobial contact lenses
10/23/2008WO2008071966A3 Pharmaceutical composition of zolpidem
10/23/2008WO2008070350A9 Methods and compositions related to wrapping of dehydrons
10/23/2008WO2008070317A3 A method for the treatment of psoriasis
10/23/2008WO2008067121A3 Methods of treating cognitive impairment and dementia
10/23/2008WO2008064829A3 Novel aminothienopyridinone derivatives processes for preparing them and pharmaceutical compositions thereof
10/23/2008WO2008063772A3 Resolvin d series and protectin d1 mitigate acute kidney injury
10/23/2008WO2008062296A3 Nop receptor agonists for the treatment of l-dopa induced dyskinesias
10/23/2008WO2008062273A8 Solid oral dosage form having antidiabetic drug combination
10/23/2008WO2008061720A3 Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders
10/23/2008WO2008053341A3 Bridged bicyclic indazoles as cannabinoid receptor ligands
10/23/2008WO2008053330A3 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii)
10/23/2008WO2008048410A3 Diagnostic methods and genetic markers for alzheimer disease
10/23/2008WO2008042898A3 Ketoconazole enantiomer in humans
1 ... 3027 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 ... 7860